Trial Condition(s):

Rhinitis, Allergic

A study to learn what participants think of treatment with betamethasone plus loratadine to treat their acute allergic rhinitis, also known as hay fever in Mexico

Bayer Identifier:

21614

ClinicalTrials.gov Identifier:

NCT04645979

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Inclusion Criteria
- Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
- Participants allowing to use the data for research and marketing purposes as well as talking to authorities
- Participants allowing us to use the pseudo-randomized individual data for further data analysis
- Able to read and understand the language of the online questionnaire
Exclusion Criteria
- None

Trial Summary

Enrollment Goal
153
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Betamethasone/Loratadine (BAY987498)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many locations

Many locations, Mexico

Status
Not yet recruiting
 

Trial Design